Jefferies Financial Group Issues Positive Forecast for Henry Schein (NASDAQ:HSIC) Stock Price

Henry Schein (NASDAQ:HSIC) had its price target hoisted by investment analysts at Jefferies Financial Group from $77.00 to $80.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “hold” rating on the stock. Jefferies Financial Group’s price objective suggests a potential upside of 8.10% from the stock’s previous close.

Several other brokerages have also commented on HSIC. Evercore ISI raised their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Finally, Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Seven analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Price Performance

Shares of HSIC stock traded down $0.77 during trading hours on Thursday, hitting $74.01. 192,197 shares of the company’s stock were exchanged, compared to its average volume of 984,536. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $9.23 billion, a PE ratio of 30.49, a PEG ratio of 2.03 and a beta of 0.89. The business’s 50 day simple moving average is $72.70 and its 200-day simple moving average is $70.86. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.32 earnings per share. On average, equities research analysts anticipate that Henry Schein will post 4.78 earnings per share for the current year.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is currently owned by company insiders.

Institutional Trading of Henry Schein

A number of hedge funds have recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC raised its holdings in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Versant Capital Management Inc increased its holdings in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. City State Bank bought a new position in Henry Schein in the fourth quarter worth approximately $55,000. Farther Finance Advisors LLC lifted its holdings in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its position in Henry Schein by 282.1% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.